Your browser doesn't support javascript.
loading
Recombinant human insulin-like growth factor-1 therapy for 6 months improves growth but not motor function in boys with Duchenne muscular dystrophy.
Rutter, Meilan M; Wong, Brenda L; Collins, James J; Sawnani, Hemant; Taylor, Michael D; Horn, Paul S; Backeljauw, Philippe F.
Affiliation
  • Rutter MM; Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Wong BL; Department of Pediatrics and Neurology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • Collins JJ; Mercy Clinic Pediatric Neurology, Springfield, Missouri, USA.
  • Sawnani H; Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Taylor MD; The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Horn PS; Division of Pediatric Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Backeljauw PF; Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Muscle Nerve ; 61(5): 623-631, 2020 05.
Article in En | MEDLINE | ID: mdl-32108355

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Body Height / Recombinant Proteins / Insulin Resistance / Insulin-Like Growth Factor I / Growth Substances / Muscular Dystrophy, Duchenne / Muscle Strength Type of study: Clinical_trials Limits: Child / Humans / Male Language: En Journal: Muscle Nerve Year: 2020 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Body Height / Recombinant Proteins / Insulin Resistance / Insulin-Like Growth Factor I / Growth Substances / Muscular Dystrophy, Duchenne / Muscle Strength Type of study: Clinical_trials Limits: Child / Humans / Male Language: En Journal: Muscle Nerve Year: 2020 Type: Article Affiliation country: United States